Literature DB >> 24377456

Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis.

Edoardo Rosato1, Antonietta Gigante1, Maria Ludovica Gasperini1, Ilenia Molinaro1, Gianluca Di Lazzaro Giraldi1, Antonella Afeltra2, Daria Amoroso1, Felice Salsano1, Filippo Rossi Fanelli1, Alessandro Laviano3.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a multisystemic chronic disease that is complicated by protein-energy malnutrition (PEM). Considering that PEM also may influence left ventricular mass (LVM), the aim of this study was to evaluate whether LVM is related to patients' nutritional status and to determine clinically relevant features of SSc.
METHODS: Adult patients referring to our institution were considered. Body weight, height, body mass index (BMI), involuntary weight loss, and the presence of gastrointestinal symptoms were recorded. Echocardiography was performed to assess LVM, using the Devereux regression formula. Results were then normalized by body surface area. Pattern, skin thickening, disease activity and severity, and duration were assessed to characterize SSc.
RESULTS: Ninety-four patents with SSc (81 women and 13 men; median duration of disease 7 y) were studied. The prevalence of PEM as assessed by BMI < 20 kg/m(2) was 19%, whereas 15% of patients reported involuntary weight loss of any degree. Patients who lost weight reported gastrointestinal symptoms more frequently (P < 0.05). PEM was not associated with disease activity. LVM (g/m(2)) correlated with patients' BMI (r = 0.32; P < 0.01), and the vascular domain of disease severity (DDS; r = 0.21; P < 0.05), but it showed a negative correlation with skin thickening (r = -0.21 P = 0.01). Patients with ulcers had a significantly greater LVM than patients without skin lesions.
CONCLUSIONS: Our study shows that LVM correlates with patients' BMI, skin thickening, and the vascular domain of DSS. Therefore, LVM could serve as a marker of nutritional status and fibrosis in patients with SSc.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Gastrointestinal symptoms; Left ventricular mass; Protein–energy malnutrition; Skin thickening; Systemic sclerosis; Weight loss

Mesh:

Year:  2014        PMID: 24377456     DOI: 10.1016/j.nut.2013.07.025

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

1.  Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality.

Authors:  Alicia M Hinze; Jamie Perin; Adrianne Woods; Laura K Hummers; Fredrick M Wigley; Monica Mukherjee; Ami A Shah
Journal:  Arthritis Rheumatol       Date:  2022-03-30       Impact factor: 15.483

2.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

3.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

4.  Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.

Authors:  Antonietta Gigante; Giuseppe Barilaro; Biagio Barbano; Antonella Romaniello; Francesca Di Mario; Silvia Quarta; Maria Ludovica Gasperini; Gianluca Di Lazzaro Giraldi; Alessandro Laviano; Antonio Amoroso; Rosario Cianci; Edoardo Rosato
Journal:  Cardiorenal Med       Date:  2016-01-23       Impact factor: 2.041

5.  Left ventricular mass correlates with lean body mass in patients with disease-associated wasting.

Authors:  Alessio Molfino; Alessia Papa; Maria L Gasperini-Zacco; Maurizio Muscaritoli; Antonio Amoroso; Antonia Cascino; Carlo Catalano; Carlina V Albanese; Alessandro Laviano
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-06-05       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.